Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Hello, everyone, and thank you for holding, and welcome to the ...

FDA's Orange Book: Iterum has submitted patent information for four U.S. patents for ORLYNVAH TM that will be listed in FDA's Orange Book: Approved Drug Products with Therapeutic Equivalence ...

The Company currently has 12 listed patents for IGALMI in the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) with expiration dates between 2037 and 2043. Recently ...

The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...